Quiza, Zion Asher Q.
HRN: 28-04-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/04/2025
11/11/2025
IV DRIP
375mg
Q6
PCAP-C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes